WHO ICTRP trial
Effect of adding geniculate block to adductor block
IRCT20230518058225N7 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20230518058225N7 |
|---|---|
| Public title | Effect of adding geniculate block to adductor block |
| Scientific title | Investigating the effect of adding geniculate block to adductor block on pain after total knee arthroplasty surgery |
| Primary sponsor | Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Pain. Pain, not elsewhere classified |
| Interventions | Intervention 1: Intervention group 1: In the adductor canal block group, patients will receive 1 mg of midazolam (1 mg/cc - manufacturer: Abu Raihan Pharmaceutical Company) as a sedative after monitoring in the preoperative recovery. Then… |
| Registration date | Dec 30, 2024 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: